Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Journal of Neuromuscular Diseases
|
December 18, 2023
Toward an Understanding of GSD5 (McArdle disease): How Do Individuals Learn to Live with the Metabolic Defect in Daily Life
Walaa Karazi, Jacqueline Coppers, Daphne Maas, et al.
Genes
|
September 27, 2025
Rhabdomyolysis in the Era of Next-Generation Sequencing: Selecting Patients with a High Likelihood of a Genetic Susceptibility Using 'RHABDO' Features
Nick Kruijt, Sanne A J H van de Camp, Jasper J Kramer, et al.
EMBO Reports
|
June 21, 2008
The death domain-containing kinase RIP1 regulates p27(Kip1) levels through the PI3K-Akt-forkhead pathway
Seongmi Park, Deepti B Ramnarain, Kimmo J Hatanpaa, et al.
Muscle & Nerve
|
November 8, 2024
A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis
Salman Bhai, Todd Levine, Dan Moore, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Journal of Neuromuscular Diseases
|
December 18, 2023
Toward an Understanding of GSD5 (McArdle disease): How Do Individuals Learn to Live with the Metabolic Defect in Daily Life
Walaa Karazi, Jacqueline Coppers, Daphne Maas, et al.
Genes
|
September 27, 2025
Rhabdomyolysis in the Era of Next-Generation Sequencing: Selecting Patients with a High Likelihood of a Genetic Susceptibility Using 'RHABDO' Features
Nick Kruijt, Sanne A J H van de Camp, Jasper J Kramer, et al.
EMBO Reports
|
June 21, 2008
The death domain-containing kinase RIP1 regulates p27(Kip1) levels through the PI3K-Akt-forkhead pathway
Seongmi Park, Deepti B Ramnarain, Kimmo J Hatanpaa, et al.
Muscle & Nerve
|
November 8, 2024
A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis
Salman Bhai, Todd Levine, Dan Moore, et al.
Page
of 3